riboflavin concentration in breastmilk
Related entities
Findings (27)
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81
None
adverseFlash-heat treatment significantly reduced riboflavin (vitamin B2) concentration in breastmilk from HIV-positive mothers to 59% of unheated levels, making it the most affected vitamin.
Effect: adverse; 0.59; CI: 95% CI 0.44 to 0.81